Skip to main content
. Author manuscript; available in PMC: 2012 Aug 1.
Published in final edited form as: Cancer Res. 2011 Jul 19;71(15):5062–5066. doi: 10.1158/0008-5472.CAN-11-0277

Figure 1.

Figure 1

A diagram showing microenvironment-specific responses to front-line chemotherapy. (Left) Systemic chemotherapy can effectively clear the majority of lymphoid tumor cells. (Right) However, genotoxic damage can also engage organ and cell-type specific stress responses. Paracrine pro-survival signaling in select tumor microenvironments can counter the efficacy of anti-cancer agents, leading to the persistence of minimal residual disease.